(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, May 04, 2021, 08:35 /Comserve / -- U.S. Compounding Pharmaceutical Market Opportunities, Size, Share, Emerging Trends, Technological Innovation, Forecasts & Regional Analysis
USA compounding pharmaceutical Market is valued approximately at USD 4.51 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2020-2027. Compounding is the preparation of a personalized drug mixture to meet a patient's specific need that cannot be fulfilled by drugs that are commercially available. The compounding pharmaceuticals is gaining a significant demand from various therapeutic areas such pain medication, dermatological applications, hormone replacement therapies and others. Therefore, rising number of skin conditions is stimulating the growth of market over the forecast years. According to the American Academy of Dermatology Association, the primary skin conditions rampant among individuals in the United States include acne, psoriasis and atopic dermatitis. The compounding pharmaceuticals are precisely recommended by the doctors & dermatologists for the common skin conditions such as acne and psoriasis. Acne is the most common skin condition which affects around 50 million American population every year. Around 85% of the individuals belonging to the age group of 12 to 24 years suffers at least one minor acne. In the present scenario, acne is on the escalating mode in the United States subsequently affecting up to 15% of female population in the country.
Get a Sample Copy of the Report:
In addition, Atopic dermatitis is considered as one of the leading skin conditions prevalent among the American population. According to American Academy of Dermatology Association, 1 in 10 individuals in United States would develop atopic dermatitis during their lifetime. The prevalence of atopic dermatitis impacts around 25% of the adolescent and 2-3% of adults in United States every year. Additionally, surging rate of geriatric population is driving the growth of market over the forecast years. However, Denied approval from Food & Drug administration for compounding pharmaceuticals is restraining the growth of market.
Major market player included in this report are:
Fagron
Institutional pharmacy solutions
B.Braun Melsungen AG Company
Athenex pharma solution
Nephron pharmaceuticals corporation
Triangle compounding pharmacy
Fresenius Kabi AG
Rx3 compounding pharmacy
Clinigen group Plc
Pencol compounding pharmacy
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Type offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Product Type:
Oral medications
Topical medications
Suppositories
Others
By Therapeutic area:
Pain medications
Hormone replacement therapies
Dermatological applications
Others
By Distribution Channel:
Compounding pharmacies
Traditional stores
Get a Sample Copy of the Report:
Furthermore, years considered for the study are as follows:
Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027
Target Audience of the USA compounding pharmaceutical Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Content
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. USA & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Compounding Pharmaceuticals Market, by Product Type, 2018-2027 (USD Billion)
1.2.2. Compounding Pharmaceuticals Market, by Therapeutic area, 2018-2027 (USD Billion)
1.2.3. Compounding Pharmaceuticals Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. USA Compounding Pharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. USA Compounding Pharmaceuticals Market Dynamics
3.1. Compounding Pharmaceuticals Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. USA Compounding Pharmaceuticals Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. USA Compounding Pharmaceuticals Market, by Product Type
5.1. Market Snapshot
5.2. USA Compounding Pharmaceuticals Market by Product Type, Performance - Potential Analysis
5.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Oral medications
5.4.2. Topical medications
5.4.3. Suppositories
5.4.4. Others
Chapter 6. USA Compounding Pharmaceuticals Market, by Therapeutic area
6.1. Market Snapshot
6.2. USA Compounding Pharmaceuticals Market by Therapeutic area, Performance - Potential Analysis
6.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Therapeutic area 2017-2027 (USD Billion)
6.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Pain medications
6.4.2. Hormone replacement therapies
6.4.3. Dermatological applications
6.4.4. Others
For more information about this report visit: USA compounding pharmaceutical Market "
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Hina Miyazu Shibuya Data Count
Email:
Tel: + 81 3 45720790
MENAFN04052021004694010674ID1102026312
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.